{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:05:23Z","timestamp":1792073123654,"version":"4.4.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100019926","name":"Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["016.196.310"],"award-info":[{"award-number":["016.196.310"]}],"id":[{"id":"10.13039\/501100019926","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although the pathology of X-linked adrenoleukodystrophy (ALD) is well described, it represents the end-stage of neurodegeneration. It is still unclear what cell types are initially involved and what their role is in the disease process. Revisiting the seminal post-mortem studies from the 1970s can generate new hypotheses on pathophysiology. This review describes (histo)pathological changes of the brain and spinal cord in ALD. It aims at integrating older works with current insights and at providing an overarching theory on the pathophysiology of ALD. The data point to an important role for axons and glia in the pathology of both the myelopathy and leukodystrophy of ALD. In-depth pathological analyses with new techniques could help further unravel the sequence of events behind the pathology of ALD.<\/jats:p>","DOI":"10.1186\/s13023-024-03105-0","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T10:01:53Z","timestamp":1711620113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The pathology of X-linked adrenoleukodystrophy: tissue specific changes as a clue to pathophysiology"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7973-2724","authenticated-orcid":false,"given":"Hemmo A.F.","family":"Yska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Bugiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"issue":"10","key":"3105_CR1","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1212\/WNL.31.10.1241","volume":"31","author":"HW Moser","year":"1981","unstructured":"Moser HW, Moser AB, Frayer KK, Chen W, Schulman JD, O\u2019Neill BP, Kishimoto Y. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology. 1981;31(10):1241\u20139.","journal-title":"Neurology"},{"issue":"100","key":"3105_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.biochi.2013.11.023","volume":"98","author":"J Berger","year":"2014","unstructured":"Berger J, Forss-Petter S, Eichler FS. Pathophysiology of X-linked adrenoleukodystrophy. Biochimie. 2014;98(100):135\u201342.","journal-title":"Biochimie"},{"issue":"2","key":"3105_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/jnen\/59.2.89","volume":"59","author":"JM Powers","year":"2000","unstructured":"Powers JM, DeCiero DP, Ito M, Moser AB, Moser HW. Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J Neuropathol Exp Neurol. 2000;59(2):89\u2013102.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"3105_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1471-4159.1976.tb04461.x-i1","volume":"26","author":"M Igarashi","year":"1976","unstructured":"Igarashi M, Schaumburg HH, Powers J, Kishmoto Y, Kolodny E, Suzuki K. Fatty acid abnormality in adrenoleukodystrophy. J Neurochem. 1976;26(4):851\u201360.","journal-title":"J Neurochem"},{"issue":"3","key":"3105_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1203\/00006450-198403000-00016","volume":"18","author":"I Singh","year":"1984","unstructured":"Singh I, Moser AE, Moser HW, Kishimoto Y. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes. Pediatr Res. 1984;18(3):286\u201390.","journal-title":"Pediatr Res"},{"issue":"2","key":"3105_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/hmg\/3.2.265","volume":"3","author":"J Mosser","year":"1994","unstructured":"Mosser J, Lutz Y, Stoeckel ME, Sarde CO, Kretz C, Douar AM, et al. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet. 1994;3(2):265\u201371.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"3105_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/jdn.10003","volume":"80","author":"BR Turk","year":"2020","unstructured":"Turk BR, Theda C, Fatemi A, Moser AB. X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies. Int J Dev Neurosci. 2020;80(1):52\u201372.","journal-title":"Int J Dev Neurosci"},{"issue":"12","key":"3105_CR8","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1093\/hmg\/ddn066","volume":"17","author":"S Hein","year":"2008","unstructured":"Hein S, Sch\u00f6nfeld P, Kahlert S, Reiser G. Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum Mol Genet. 2008;17(12):1750\u201361.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"3105_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1172\/JCI118182","volume":"96","author":"JK Ho","year":"1995","unstructured":"Ho JK, Moser H, Kishimoto Y, Hamilton JA. Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy. J Clin Invest. 1995;96(3):1455\u201363.","journal-title":"J Clin Invest"},{"issue":"3","key":"3105_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF00312873","volume":"213","author":"H Budka","year":"1976","unstructured":"Budka H, Sluga E, Heiss WD. Spastic paraplegia associated with Addison\u2019s disease: adult variant of adreno-leukodystrophy. J Neurol. 1976;213(3):237\u201350.","journal-title":"J Neurol"},{"issue":"9","key":"3105_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/archneur.1975.00490510033001","volume":"32","author":"HH Schaumburg","year":"1975","unstructured":"Schaumburg HH, Powers JM, Raine CS, Suzuki K, Richardson EP. Jr. Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol. 1975;32(9):577\u201391.","journal-title":"Arch Neurol"},{"issue":"5","key":"3105_CR12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/archneur.1974.00490350064011","volume":"30","author":"JM Powers","year":"1974","unstructured":"Powers JM, Schaumberg HH. Adreno-leukodystrophy. Similar ultrastructural changes in adrenal cortical and Schwann cells. Arch Neurol. 1974;30(5):406\u20138.","journal-title":"Arch Neurol"},{"issue":"6","key":"3105_CR13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/24.6.59773","volume":"24","author":"AB Johnson","year":"1976","unstructured":"Johnson AB, Schaumburg HH, Powers JM. Histochemical characteristics of the striated inclusions of adrenoleukodystrophy. J Histochem Cytochem. 1976;24(6):725\u201330.","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"3105_CR14","first-page":"90","volume":"102","author":"JM Powers","year":"1981","unstructured":"Powers JM, Schaumburg HH. The testis in adreno-leukodystrophy. Am J Pathol. 1981;102(1):90\u20138.","journal-title":"Am J Pathol"},{"issue":"18","key":"3105_CR15","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1093\/hmg\/ddx249","volume":"26","author":"LR Strachan","year":"2017","unstructured":"Strachan LR, Stevenson TJ, Freshner B, Keefe MD, Miranda Bowles D, Bonkowsky JL. A zebrafish model of X-linked adrenoleukodystrophy recapitulates key disease features and demonstrates a developmental requirement for abcd1 in oligodendrocyte patterning and myelination. Hum Mol Genet. 2017;26(18):3600\u201314.","journal-title":"Hum Mol Genet"},{"issue":"17","key":"3105_CR16","doi-asserted-by":"publisher","first-page":"9366","DOI":"10.1073\/pnas.94.17.9366","volume":"94","author":"JF Lu","year":"1997","unstructured":"Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, Smith KD. A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci U S A. 1997;94(17):9366\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3105_CR17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ana.410070607","volume":"7","author":"HW Moser","year":"1980","unstructured":"Moser HW, Moser AB, Kawamura N, Murphy J, Suzuki K, Schaumburg H, Kishimoto Y. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts. Ann Neurol. 1980;7(6):542\u20139.","journal-title":"Ann Neurol"},{"issue":"3","key":"3105_CR18","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/jimd.12357","volume":"44","author":"R Montoro","year":"2021","unstructured":"Montoro R, Heine VM, Kemp S, Engelen M. Evolution of adrenoleukodystrophy model systems. J Inherit Metab Dis. 2021;44(3):544\u201353.","journal-title":"J Inherit Metab Dis"},{"issue":"2\u20133","key":"3105_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0014-5793(94)00400-5","volume":"344","author":"M Contreras","year":"1994","unstructured":"Contreras M, Mosser J, Mandel JL, Aubourg P, Singh I. The protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein. FEBS Lett. 1994;344(2\u20133):211\u20135.","journal-title":"FEBS Lett"},{"issue":"46","key":"3105_CR20","doi-asserted-by":"publisher","first-page":"32738","DOI":"10.1074\/jbc.274.46.32738","volume":"274","author":"LX Liu","year":"1999","unstructured":"Liu LX, Janvier K, Berteaux-Lecellier V, Cartier N, Benarous R, Aubourg P. Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters. J Biol Chem. 1999;274(46):32738\u201343.","journal-title":"J Biol Chem"},{"issue":"26","key":"3105_CR21","doi-asserted-by":"publisher","first-page":"19269","DOI":"10.1074\/jbc.M112.445445","volume":"288","author":"C Wiesinger","year":"2013","unstructured":"Wiesinger C, Kunze M, Regelsberger G, Forss-Petter S, Berger J. Impaired very long-chain acyl-CoA \u03b2-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction. J Biol Chem. 2013;288(26):19269\u201379.","journal-title":"J Biol Chem"},{"issue":"5","key":"3105_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/hmg\/8.5.907","volume":"8","author":"A Netik","year":"1999","unstructured":"Netik A, Forss-Petter S, Holzinger A, Molzer B, Unterrainer G, Berger J. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. Hum Mol Genet. 1999;8(5):907\u201313.","journal-title":"Hum Mol Genet"},{"issue":"23","key":"3105_CR23","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1093\/hmg\/ddh323","volume":"13","author":"A Pujol","year":"2004","unstructured":"Pujol A, Ferrer I, Camps C, Metzger E, Hindelang C, Callizot N, et al. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum Mol Genet. 2004;13(23):2997\u20133006.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"3105_CR24","doi-asserted-by":"publisher","first-page":"e108655","DOI":"10.1371\/journal.pone.0108655","volume":"9","author":"Z Muneer","year":"2014","unstructured":"Muneer Z, Wiesinger C, Voigtl\u00e4nder T, Werner HB, Berger J, Forss-Petter S. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice. PLoS ONE. 2014;9(9):e108655.","journal-title":"PLoS ONE"},{"issue":"2","key":"3105_CR25","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1046\/j.1432-1327.1999.00772.x","volume":"265","author":"J Berger","year":"1999","unstructured":"Berger J, Albet S, Bentejac M, Netik A, Holzinger A, Roscher AA, et al. The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression. Eur J Biochem. 1999;265(2):719\u201327.","journal-title":"Eur J Biochem"},{"issue":"1","key":"3105_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bbrc.2008.09.092","volume":"377","author":"EM Maier","year":"2008","unstructured":"Maier EM, Mayerhofer PU, Asheuer M, K\u00f6hler W, Rothe M, Muntau AC, et al. X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype. Biochem Biophys Res Commun. 2008;377(1):176\u201380.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"3105_CR27","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1373\/clinchem.2004.038539","volume":"50","author":"S Kemp","year":"2004","unstructured":"Kemp S, Valianpour F, Mooyer PA, Kulik W, Wanders RJ. Method for measurement of peroxisomal very-long-chain fatty acid beta-oxidation in human skin fibroblasts using stable-isotope-labeled tetracosanoic acid. Clin Chem. 2004;50(10):1824\u20136.","journal-title":"Clin Chem"},{"issue":"12","key":"3105_CR28","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1096\/fj.08-110866","volume":"22","author":"CW van Roermund","year":"2008","unstructured":"van Roermund CW, Visser WF, Ijlst L, van Cruchten A, Boek M, Kulik W, et al. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. Faseb j. 2008;22(12):4201\u20138.","journal-title":"Faseb j"},{"issue":"12","key":"3105_CR29","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/hmg\/ddn085","volume":"17","author":"S Fourcade","year":"2008","unstructured":"Fourcade S, L\u00f3pez-Erauskin J, Galino J, Duval C, Naudi A, Jove M, et al. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet. 2008;17(12):1762\u201373.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"3105_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/WCO.0000000000000334","volume":"29","author":"MH Barnett","year":"2016","unstructured":"Barnett MH, Mathey E, Kiernan MC, Pollard JD. Axonal damage in central and peripheral nervous system inflammatory demyelinating diseases: common and divergent pathways of tissue damage. Curr Opin Neurol. 2016;29(3):213\u201321.","journal-title":"Curr Opin Neurol"},{"key":"3105_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cellimm.2018.01.004","volume":"330","author":"D Low","year":"2018","unstructured":"Low D, Ginhoux F. Recent advances in the understanding of microglial development and homeostasis. Cell Immunol. 2018;330:68\u201378.","journal-title":"Cell Immunol"},{"issue":"4","key":"3105_CR32","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1750-3639.2010.00392.x","volume":"20","author":"I Singh","year":"2010","unstructured":"Singh I, Pujol A. Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis. Brain Pathol. 2010;20(4):838\u201344.","journal-title":"Brain Pathol"},{"issue":"4","key":"3105_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","volume":"24","author":"GH Kim","year":"2015","unstructured":"Kim GH, Kim JE, Rhie SJ, Yoon S. The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol. 2015;24(4):325\u201340.","journal-title":"Exp Neurobiol"},{"issue":"10","key":"3105_CR34","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s11910-014-0486-0","volume":"14","author":"M Engelen","year":"2014","unstructured":"Engelen M, Kemp S, Poll-The BT. X-linked adrenoleukodystrophy: pathogenesis and treatment. Curr Neurol Neurosci Rep. 2014;14(10):486.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"3105_CR35","first-page":"181","volume":"4","author":"JM Powers","year":"1985","unstructured":"Powers JM. Adreno-leukodystrophy (adreno-testiculo-leukomyelo-neuropathic-complex). Clin Neuropathol. 1985;4(5):181\u201399.","journal-title":"Clin Neuropathol"},{"issue":"4","key":"3105_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1006\/nbdi.1997.0127","volume":"3","author":"F Fouquet","year":"1997","unstructured":"Fouquet F, Zhou JM, Ralston E, Murray K, Troalen F, Magal E, et al. Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system. Neurobiol Dis. 1997;3(4):271\u201385.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"3105_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.nbd.2007.07.007","volume":"28","author":"R H\u00f6ftberger","year":"2007","unstructured":"H\u00f6ftberger R, Kunze M, Weinhofer I, Aboul-Enein F, Voigtl\u00e4nder T, Oezen I, et al. Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy. Neurobiol Dis. 2007;28(2):165\u201374.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"3105_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-021-02391-3","volume":"143","author":"M Bugiani","year":"2022","unstructured":"Bugiani M, Plug BC, Man JHK, Breur M, van der Knaap MS. Heterogeneity of white matter astrocytes in the human brain. Acta Neuropathol. 2022;143(2):159\u201377.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"3105_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF00690750","volume":"49","author":"A Probst","year":"1980","unstructured":"Probst A, Ulrich J, Heitz PU, Herschkowitz N. Adrenomyeloneuropathy. A protracted, pseudosystematic variant of adrenoleukodystrophy. Acta Neuropathol. 1980;49(2):105\u201315.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"3105_CR40","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1212\/WNL.27.12.1114","volume":"27","author":"HH Schaumburg","year":"1977","unstructured":"Schaumburg HH, Powers JM, Raine CS, Spencer PS, Griffin JW, Prineas JW, Boehme DM. Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. Neurology. 1977;27(12):1114\u20139.","journal-title":"Neurology"},{"issue":"12","key":"3105_CR41","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1212\/01.wnl.0000276945.92950.69","volume":"69","author":"S Marino","year":"2007","unstructured":"Marino S, De Luca M, Dotti MT, Stromillo ML, Formichi P, Galluzzi P, et al. Prominent brain axonal damage and functional reorganization in pure adrenomyeloneuropathy. Neurology. 2007;69(12):1261\u20139.","journal-title":"Neurology"},{"issue":"3","key":"3105_CR42","first-page":"481","volume":"76","author":"JM Powers","year":"1974","unstructured":"Powers JM, Schaumburg HH. Adreno-Leukodystrophy (sex-linked Schilder\u2019s disease). A pathogenetic hypothesis based on ultrastructural lesions in adrenal cortex, peripheral nerve and testis. Am J Pathol. 1974;76(3):481\u201391.","journal-title":"Am J Pathol"},{"issue":"1","key":"3105_CR43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1212\/WNL.46.1.112","volume":"46","author":"BM van Geel","year":"1996","unstructured":"van Geel BM, Koelman JH, Barth PG, Ongerboer de Visser BW. Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study. Neurology. 1996;46(1):112\u20138.","journal-title":"Neurology"},{"issue":"19","key":"3105_CR44","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1212\/WNL.0000000000000415","volume":"82","author":"MA Horn","year":"2014","unstructured":"Horn MA, Nilsen KB, J\u00f8rum E, Mellgren SI, Tallaksen CM. Small nerve fiber involvement is frequent in X-linked adrenoleukodystrophy. Neurology. 2014;82(19):1678\u201383.","journal-title":"Neurology"},{"issue":"5","key":"3105_CR45","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/ana.25085","volume":"82","author":"Y Gong","year":"2017","unstructured":"Gong Y, Sasidharan N, Laheji F, Frosch M, Musolino P, Tanzi R, et al. Microglial dysfunction as a key pathological change in adrenomyeloneuropathy. Ann Neurol. 2017;82(5):813\u201327.","journal-title":"Ann Neurol"},{"key":"3105_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1750-1172-7-51","volume":"7","author":"M Engelen","year":"2012","unstructured":"Engelen M, Kemp S, de Visser M, van Geel BM, Wanders RJ, Aubourg P, Poll-The BT. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis. 2012;7:51.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3105_CR47","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1001\/archneur.1974.00490390092013","volume":"31","author":"HH Schaumburg","year":"1974","unstructured":"Schaumburg HH, Powers JM, Suzuki K, Raine CS. Adreno-Leukodystrophy (sex-linked Schilder disease). Ultrastructural demonstration of specific cytoplasmic inclusions in the central nervous system. Arch Neurol. 1974;31(3):210\u20133.","journal-title":"Arch Neurol"},{"issue":"6","key":"3105_CR48","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/00005072-199211000-00007","volume":"51","author":"JM Powers","year":"1992","unstructured":"Powers JM, Liu Y, Moser AB, Moser HW. The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol. 1992;51(6):630\u201343.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"3105_CR49","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/jnen\/60.10.1004","volume":"60","author":"M Ito","year":"2001","unstructured":"Ito M, Blumberg BM, Mock DJ, Goodman AD, Moser AB, Moser HW, et al. Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol. 2001;60(10):1004\u201319.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"3105_CR50","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.21391","volume":"63","author":"FS Eichler","year":"2008","unstructured":"Eichler FS, Ren JQ, Cossoy M, Rietsch AM, Nagpal S, Moser AB, et al. Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? Ann Neurol. 2008;63(6):729\u201342.","journal-title":"Ann Neurol"},{"issue":"3","key":"3105_CR51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3174\/ajnr.A2327","volume":"32","author":"JP van der Voorn","year":"2011","unstructured":"van der Voorn JP, Pouwels PJ, Powers JM, Kamphorst W, Martin JJ, Troost D, et al. Correlating quantitative MR imaging with histopathology in X-linked adrenoleukodystrophy. AJNR Am J Neuroradiol. 2011;32(3):481\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"3105_CR52","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1002\/glia.24042","volume":"69","author":"CG Bergner","year":"2021","unstructured":"Bergner CG, Genc N, Hametner S, Franz J, van der Meer F, Mitkovski M, et al. Concurrent axon and myelin destruction differentiates X-linked adrenoleukodystrophy from multiple sclerosis. Glia. 2021;69(10):2362\u201377.","journal-title":"Glia"},{"key":"3105_CR53","doi-asserted-by":"publisher","first-page":"104781","DOI":"10.1016\/j.ebiom.2023.104781","volume":"96","author":"I Weinhofer","year":"2023","unstructured":"Weinhofer I, Rommer P, Gleiss A, Ponleitner M, Zierfuss B, Waidhofer-S\u00f6llner P, et al. Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy. EBioMedicine. 2023;96:104781.","journal-title":"EBioMedicine"},{"issue":"4","key":"3105_CR54","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/ana.410230405","volume":"23","author":"KW Selmaj","year":"1988","unstructured":"Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol. 1988;23(4):339\u201346.","journal-title":"Ann Neurol"},{"issue":"4","key":"3105_CR55","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/nan.12399","volume":"44","author":"AL G\u00f6rtz","year":"2018","unstructured":"G\u00f6rtz AL, Peferoen LAN, Gerritsen WH, van Noort JM, Bugiani M, Amor S. Heat shock protein expression in cerebral X-linked adrenoleukodystrophy reveals astrocyte stress prior to myelin loss. Neuropathol Appl Neurobiol. 2018;44(4):363\u201376.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"3105_CR56","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/jcb.26295","volume":"119","author":"DP Marchetti","year":"2018","unstructured":"Marchetti DP, Donida B, Jacques CE, Deon M, Hauschild TC, Koehler-Santos P, et al. Inflammatory profile in X-linked adrenoleukodystrophy patients: understanding disease progression. J Cell Biochem. 2018;119(1):1223\u201333.","journal-title":"J Cell Biochem"},{"issue":"1","key":"3105_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/1090-3798(98)01002-7","volume":"2","author":"A Lannuzel","year":"1998","unstructured":"Lannuzel A, Aubourg P, Tardieu M. Excessive production of tumour necrosis factor alpha by peripheral blood mononuclear cells in X-linked adrenoleukodystrophy. Eur J Paediatr Neurol. 1998;2(1):27\u201332.","journal-title":"Eur J Paediatr Neurol"},{"issue":"8","key":"3105_CR58","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1093\/brain\/awy127","volume":"141","author":"I Weinhofer","year":"2018","unstructured":"Weinhofer I, Zierfuss B, Hametner S, Wagner M, Popitsch N, Machacek C, et al. Impaired plasticity of macrophages in X-linked adrenoleukodystrophy. Brain. 2018;141(8):2329\u201342.","journal-title":"Brain"},{"issue":"6","key":"3105_CR59","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/glia.23598","volume":"67","author":"CG Bergner","year":"2019","unstructured":"Bergner CG, van der Meer F, Winkler A, Wrzos C, T\u00fcrkmen M, Valizada E, et al. Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy. Glia. 2019;67(6):1196\u2013209.","journal-title":"Glia"},{"issue":"3","key":"3105_CR60","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00401-014-1330-y","volume":"128","author":"N Cartier","year":"2014","unstructured":"Cartier N, Lewis CA, Zhang R, Rossi FM. The role of microglia in human disease: therapeutic tool or target? Acta Neuropathol. 2014;128(3):363\u201380.","journal-title":"Acta Neuropathol"},{"issue":"26","key":"3105_CR61","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/NEJM199006283222607","volume":"322","author":"P Aubourg","year":"1990","unstructured":"Aubourg P, Blanche S, Jambaqu\u00e9 I, Rocchiccioli F, Kalifa G, Naud-Saudreau C, et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med. 1990;322(26):1860\u20136.","journal-title":"N Engl J Med"},{"issue":"5954","key":"3105_CR62","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.1171242","volume":"326","author":"N Cartier","year":"2009","unstructured":"Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science. 2009;326(5954):818\u201323.","journal-title":"Science"},{"issue":"10","key":"3105_CR63","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1093\/hmg\/ddt645","volume":"23","author":"FD Weber","year":"2014","unstructured":"Weber FD, Wiesinger C, Forss-Petter S, Regelsberger G, Einwich A, Weber WH, et al. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes. Hum Mol Genet. 2014;23(10):2542\u201350.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"3105_CR64","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10545-014-9797-1","volume":"38","author":"BM van Geel","year":"2015","unstructured":"van Geel BM, Poll-The BT, Verrips A, Boelens JJ, Kemp S, Engelen M. Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study. J Inherit Metab Dis. 2015;38(2):359\u201361.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"3105_CR65","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00401-021-02389-x","volume":"143","author":"S Amor","year":"2022","unstructured":"Amor S, McNamara NB, Gerrits E, Marzin MC, Kooistra SM, Miron VE, Nutma E. White matter microglia heterogeneity in the CNS. Acta Neuropathol. 2022;143(2):125\u201341.","journal-title":"Acta Neuropathol"},{"key":"3105_CR66","doi-asserted-by":"publisher","first-page":"103474","DOI":"10.1016\/j.ebiom.2021.103474","volume":"69","author":"M A O, U","year":"2021","unstructured":"A O, U M, Lf B. Energy metabolism in childhood neurodevelopmental disorders. EBioMedicine. 2021;69:103474.","journal-title":"EBioMedicine"},{"issue":"12","key":"3105_CR67","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1093\/brain\/awx262","volume":"140","author":"A Lauer","year":"2017","unstructured":"Lauer A, Da X, Hansen MB, Boulouis G, Ou Y, Cai X, et al. ABCD1 dysfunction alters white matter microvascular perfusion. Brain. 2017;140(12):3139\u201352.","journal-title":"Brain"},{"issue":"Pt 11","key":"3105_CR68","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1093\/brain\/awv250","volume":"138","author":"PL Musolino","year":"2015","unstructured":"Musolino PL, Gong Y, Snyder JM, Jimenez S, Lok J, Lo EH, et al. Brain endothelial dysfunction in cerebral adrenoleukodystrophy. Brain. 2015;138(Pt 11):3206\u201320.","journal-title":"Brain"},{"issue":"2","key":"3105_CR69","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1471-4159.1983.tb04748.x","volume":"41","author":"FR Brown","year":"1983","unstructured":"Brown FR 3rd, Chen WW, Kirschner DA, Frayer KL, Powers JM, Moser AB, Moser HW. Myelin membrane from adrenoleukodystrophy brain white matter\u2013biochemical properties. J Neurochem. 1983;41(2):341\u20138.","journal-title":"J Neurochem"},{"issue":"1","key":"3105_CR70","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1471-4159.1993.tb03567.x","volume":"61","author":"R Wilson","year":"1993","unstructured":"Wilson R, Sargent JR. Lipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients. J Neurochem. 1993;61(1):290\u20137.","journal-title":"J Neurochem"},{"key":"3105_CR71","doi-asserted-by":"crossref","unstructured":"Buda A, Forss-Petter S, Hua R, Jaspers Y, Lassnig M, Waidhofer-S\u00f6llner P et al. ABCD1 Transporter Deficiency results in altered cholesterol homeostasis. Biomolecules. 2023;13(9).","DOI":"10.3390\/biom13091333"},{"issue":"3","key":"3105_CR72","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.1220","volume":"50","author":"M Di Rocco","year":"2001","unstructured":"Di Rocco M, Doria-Lamba L, Caruso U. Monozygotic twins with X-linked adrenoleukodystrophy and different phenotypes. Ann Neurol. 2001;50(3):424.","journal-title":"Ann Neurol"},{"key":"3105_CR73","first-page":"109","volume":"8","author":"C Wiesinger","year":"2015","unstructured":"Wiesinger C, Eichler FS, Berger J. The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis. Appl Clin Genet. 2015;8:109\u201321.","journal-title":"Appl Clin Genet"},{"issue":"10","key":"3105_CR74","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.bbadis.2016.07.006","volume":"1862","author":"CE van Engen","year":"2016","unstructured":"van Engen CE, Ofman R, Dijkstra IM, van Goethem TJ, Verheij E, Varin J, et al. CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acids. Biochim Biophys Acta. 2016;1862(10):1861\u201370.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"3105_CR75","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/emmm.201000061","volume":"2","author":"R Ofman","year":"2010","unstructured":"Ofman R, Dijkstra IM, van Roermund CW, Burger N, Turkenburg M, van Cruchten A, et al. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol Med. 2010;2(3):90\u20137.","journal-title":"EMBO Mol Med"},{"issue":"9","key":"3105_CR76","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.bbadis.2012.03.012","volume":"1822","author":"S Kemp","year":"2012","unstructured":"Kemp S, Berger J, Aubourg P. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects. Biochim Biophys Acta. 2012;1822(9):1465\u201374.","journal-title":"Biochim Biophys Acta"},{"key":"3105_CR77","doi-asserted-by":"crossref","unstructured":"Raas Q, van de Beek MC, Forss-Petter S, Dijkstra IM, Deschiffart A, Freshner BC et al. Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy. J Clin Invest. 2021;131(8).","DOI":"10.1172\/JCI142500"},{"issue":"4","key":"3105_CR78","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1055\/s-0041-1730937","volume":"52","author":"SIW van de Stadt","year":"2021","unstructured":"van de Stadt SIW, Huffnagel IC, Turk BR, van der Knaap MS, Engelen M. Imaging in X-Linked adrenoleukodystrophy. Neuropediatrics. 2021;52(4):252\u201360.","journal-title":"Neuropediatrics"},{"issue":"1\u20132","key":"3105_CR79","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jns.2009.11.005","volume":"290","author":"GV Raymond","year":"2010","unstructured":"Raymond GV, Seidman R, Monteith TS, Kolodny E, Sathe S, Mahmood A, Powers JM. Head trauma can initiate the onset of adreno-leukodystrophy. J Neurol Sci. 2010;290(1\u20132):70\u20134.","journal-title":"J Neurol Sci"},{"issue":"4","key":"3105_CR80","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1750-3639.2010.00394.x","volume":"20","author":"N Cartier","year":"2010","unstructured":"Cartier N, Aubourg P. Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy. Brain Pathol. 2010;20(4):857\u201362.","journal-title":"Brain Pathol"},{"issue":"12","key":"3105_CR81","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1182\/blood-2018-11-887240","volume":"133","author":"PJ Orchard","year":"2019","unstructured":"Orchard PJ, Nascene DR, Miller WP, Gupta A, Kenney-Jung D, Lund TC. Successful donor engraftment and repair of the blood-brain barrier in cerebral adrenoleukodystrophy. Blood. 2019;133(12):1378\u201381.","journal-title":"Blood"},{"issue":"6","key":"3105_CR82","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/bpa.12595","volume":"28","author":"A Schl\u00fcter","year":"2018","unstructured":"Schl\u00fcter A, Sandoval J, Fourcade S, D\u00edaz-Lagares A, Ruiz M, Casaccia P, et al. Epigenomic signature of adrenoleukodystrophy predicts compromised oligodendrocyte differentiation. Brain Pathol. 2018;28(6):902\u201319.","journal-title":"Brain Pathol"},{"key":"3105_CR83","doi-asserted-by":"crossref","unstructured":"Mallack EJ, Gao K, Engelen M, Kemp S. Structure and function of the ABCD1 variant database: 20 years, 940 pathogenic variants, and 3400 cases of Adrenoleukodystrophy. Cells. 2022;11(2).","DOI":"10.3390\/cells11020283"},{"issue":"5","key":"3105_CR84","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/1073858412465655","volume":"19","author":"SC Barnett","year":"2013","unstructured":"Barnett SC, Linington C. Myelination: do astrocytes play a role? Neuroscientist. 2013;19(5):442\u201350.","journal-title":"Neuroscientist"},{"issue":"11","key":"3105_CR85","doi-asserted-by":"publisher","first-page":"e0143238","DOI":"10.1371\/journal.pone.0143238","volume":"10","author":"M Baarine","year":"2015","unstructured":"Baarine M, Khan M, Singh A, Singh I. Functional characterization of IPSC-Derived brain cells as a model for X-Linked adrenoleukodystrophy. PLoS ONE. 2015;10(11):e0143238.","journal-title":"PLoS ONE"},{"issue":"3","key":"3105_CR86","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-017-1739-1","volume":"134","author":"MS van der Knaap","year":"2017","unstructured":"van der Knaap MS, Bugiani M. Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms. Acta Neuropathol. 2017;134(3):351\u201382.","journal-title":"Acta Neuropathol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03105-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03105-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03105-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T21:01:36Z","timestamp":1713301296000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03105-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3105"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03105-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"assertion":[{"value":"18 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Incorrect body text. It contained editing and proofing text. It was published: Main text; ABCD1 and Molecular Pathology. ABCD1 and Molecular Pathology.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ME received support from Minoryx and is member of the advisory board of Minoryx, Poxel and SwanBio Therapeutics.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}